A female patient bearing a mutation containing a stop codon in the WIPF1 gene, which encodes WIP, displayed recurrent infections, eczema, thrombocytopenia, defective T cell proliferation and chemotaxis, and impaired NK cell effector function (Lanzi et al., 2012). This evidence concerns the gene WIPF1 and Eczematoid dermatitis.